EUVIMEDEUVIMED entdecken
Crossref

Serum alpha 1 antitrypsin potent act as an early diagnostic biomarker for cardiac amyloidosis

Ye Zhu, Haitao Yuan, Huiting Qu

Heart and Vessels · 2024

DOI: 10.1007/s00380-024-02396-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Heart and Vessels, 2024. Verfasst von Ye Zhu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Medicine, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China. Hauptthemen laut MEDLINE: Biomarkers, alpha 1-Antitrypsin, Amyloidosis, Cardiomyopathies. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiac amyloidosis is a refractory cardiomyopathy with a poor prognosis and lacks effective treatments. N-terminal pro-brain natriuretic peptide (NT-proBNP) and troponin T are poor prognostic factors for myocardial amyloidosis. However, NT-proBNP and troponin also serve as markers of heart failure and myocardial infarction, lacking specificity. Whether abnormal elevation of alpha-1 antitrypsin in myocardial amyloidosis also predicts the poor prognosis of patients remains unknown. We conducted a retrospective single-center case-control study to analyze the serological and physical examination data of 83 cardiac amyloidosis patients and 68 healthy controls matched by gender and age. We aimed to explore the onset and prognostic factors of cardiac amyloidosis. The serum alpha-1 antitrypsin level (169.78 ± 39.59 mg/dl) in patients with cardiac amyloidosis was significantly higher than that in the normal control (125.92 ± 18.26 mg/dl). Logistic regression results showed that alpha-1 antitrypsin, free sialic acid, high-density lipoprotein cholesterol, apolipoprotein A/B ratio, and homocysteine were predictors of cardiac amyloidosis. Multivariable logistic regression showed that only alpha 1 antitrypsin was an independent risk factor for cardiac amyloidosis. Receiver operating characteristic curve analysis based on the Mayo stage and troponin level showed the cut-off value of 140.55 mg/dl for alpha-1 antitrypsin in predicting cardiac amyloidosis with 81.7% sensitivity and 83.9% specificity. Elevated alpha-1 antitrypsin levels may be an early diagnostic biomarker for cardiac amyloidosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomarkersalpha 1-AntitrypsinAmyloidosisCardiomyopathiesHumansMaleFemaleRetrospective StudiesMiddle AgedAgedROC CurveEarly DiagnosisCase-Control StudiesPrognosisRisk Factors

Stichwörter der Autor:innen

Alpha 1 antitrypsinBiomarkerCardiac amyloidosis

Substanzen

Biomarkersalpha 1-Antitrypsin

Autor:innen und Institutionen

  • Department of Cardiac Medicine, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
  • Department of Internal Medicine, The Fifth People's Hospital of Jinan, Jinan, Shandong, China.
  • Department of Hematology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China. quht@email.sdu.edu.cn.
  • Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China. quht@email.sdu.edu.cn.

Zitieren

APA

Zhu, Y., Yuan, H., & Qu, H. (2024). Serum alpha 1 antitrypsin potent act as an early diagnostic biomarker for cardiac amyloidosis. Heart and Vessels. https://doi.org/10.1007/s00380-024-02396-4

Vancouver

Zhu Y, Yuan H, Qu H. Serum alpha 1 antitrypsin potent act as an early diagnostic biomarker for cardiac amyloidosis. Heart and Vessels. 2024. doi:10.1007/s00380-024-02396-4

BibTeX
@article{Zhu2024,
  author = {Zhu, Ye and Yuan, Haitao and Qu, Huiting},
  title = {Serum alpha 1 antitrypsin potent act as an early diagnostic biomarker for cardiac amyloidosis},
  journal = {Heart and Vessels},
  year = {2024},
  doi = {10.1007/s00380-024-02396-4}
}
Kostenlos starten →